Piloting a Home-based HIIT (High Intensity Interval Training) Intervention for People With Parkinson's
Study Details
Study Description
Brief Summary
This project aims to investigate the practicality and utility of home-based high-intensity interval training (HIIT) by piloting a previously developed, novel home-based HIIT intervention for people with Parkinson's (PwP).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Participants will be undertaking a 12-week home-based high-intensity interval training intervention. The programme is a pilot intervention, previously co-created by people with Parkinson's and clinicians within an iterative planning process of focus groups and exercise testing.
Participants will initially undertake 7 days pre-intervention, of accelerometer wearing (daytime only) following accelerometer instruction, as a baseline measure of habitual physical activity (an important confounding variable).
Following this, participants will undertake exercise programme instruction, and initial baseline assessments. These will involve collection of anthropometric measurements and general lifestyle and Parkinson's related information, followed by pre-intervention outcome measures.
Participants will then undertake a 12-week high-intensity interval training programme in the home setting, with supplied exercise equipment including music and exercise prompts, and remote support and online resources. Participants will complete a 30 minute training session 3 times per week, with at least one day of rest between sessions. Participants will also complete a self-administered outcome measure every 2 weeks. Participants will be loaned heart rate monitoring devices, which will remotely record heart rate per exercise session. During week 7 of the intervention, participants will be asked to repeat 7 days of accelerometer wearing to compare habitual physical activity. Participants will record HIIT participation / adverse effects and events / exercise adaptations in diaries during the course of the intervention.
Participants will then undergo post-intervention outcome measures. Participants will also be asked to be involved in a 45-minute post intervention focus group as part of a process evaluation. Depending on numbers, it is likely that there will be 2 of these parallel groups.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Exercise High-intensity exercise |
Other: High-intensity interval training
12-weeks of high intensity interval exercise, 30 minutes thrice weekly
|
No Intervention: Usual care Usual care / treatment. Usual physical activity. |
Outcome Measures
Primary Outcome Measures
- Change from baseline Relative VO2max [1 day before first exercise session and 1 day after last session.]
Maximal oxygen uptake (ml/min/kg) incremental exercise test
- Change from baseline brain derived neurotrophic factor (BDNF) [1 day before first exercise session and 1 day after last session.]
Blood sample: Brain-derived neurotrophic factor (pg/ml)
- Change from baseline Movement Disorder Society Unified Parkinson's Disease Rating Scale part 3 [1 day before first exercise session and 1 day after last session.]
Motor examination, minimum score 0, maximum score 76, higher scores indicate increased disease severity
- Programme completion [Through study completion, an average of 12 weeks]
Number of weeks of exercise programme completed, self administered
Secondary Outcome Measures
- Programme adherence [Through study completion, an average of 12 weeks]
Number of exercise sessions completed in full, self administered
- Exercise intensity [Through study completion, an average of 12 weeks]
Achieved exercise intensity (% of maximum heart rate), self administered
- Adverse effects and events [Through study completion, an average of 12 weeks]
Adverse effects and events related to exercise sessions, self administered
- Change from baseline 30 second sit to stand test [1 day before first exercise session and 1 day after last session.]
Number of times standing in 30 seconds
Other Outcome Measures
- Total weekly habitual physical activity [1 week prior to start of programme]
Weekly physical activity (minutes) measured with accelerometer, self administered
- Total weekly habitual physical activity [During week 7 of programme]
Weekly physical activity (minutes) measured with accelerometer, self administered
- Maximum heart rate [1 day before first exercise session]
Beats per minute, to be measured during VO2max assessment
- Height [1 day before first exercise session]
Height (centimetres) with stadiometer
- Weight [1 day before first exercise session]
Weight (kilograms) with calibrated digital scales
- Lifestyle data questionnaire [1 day before first exercise session]
10-item basic lifestyle data bespoke questionnaire
- 30 second sit to stand test [2 weeks after first exercise session]
Number of times standing in 30 seconds, self administered
- 30 second sit to stand test [4 weeks after first exercise session]
Number of times standing in 30 seconds, self administered
- 30 second sit to stand test [6 weeks after first exercise session]
Number of times standing in 30 seconds, self administered
- 30 second sit to stand test [8 weeks after first exercise session]
Number of times standing in 30 seconds, self administered
- 30 second sit to stand test [10 weeks after first exercise session]
Number of times standing in 30 seconds, self administered
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosed with Parkinson's disease
-
Hoehn and Yahr stages 1-3
-
No other pre-existing health conditions that would prevent / be exacerbated by high-intensity exercise
-
Sufficient cognitive ability to follow an exercise programme and to provide informed consent
-
Internet access
Exclusion Criteria:
-
Other forms of Parkinsonism or neurological condition
-
Hoehn and Yahr stages 4 and 5
-
Other pre-existing health conditions that would prevent / be exacerbated by high-intensity exercise
-
Insufficient cognitive ability to follow an exercise programme or provide informed consent
-
No Internet access
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Plymouth
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- UPlymouthCH